Re: Thomas Powles, Begoña Pérez-Valderrama, Shilpa Gupta, et al. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med 2024;390:875-88
1 Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain; Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain. Electronic address: egrande@oncomadrid.com.
2 Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; University of Manchester, Manchester, UK; University of Central Lancashire, Preston, UK.
3 Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.